Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2015

Open Access 01-12-2015 | Original Article

Are oxidized low-density lipoprotein and C-reactive protein markers of atherosclerosis in nephrotic children?

Authors: A. Rybi-Szumińska, A. Wasilewska, J. Michaluk-Skutnik, B. Osipiuk-Remża, R. Fiłonowicz, M. Zając

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2015

Login to get access

Abstract

Background

Lipid disorders are known to be linked to disturbance in oxidative reactions and play an important role in the progression and complications of idiopathic nephrotic syndrome (INS).

Aims

The aim of this study was to assess oxidized low-density lipoprotein (oxLDL), high-sensitive C-reactive protein (hs-CRP) serum concentrations and other parameters of lipid metabolism in children with INS during relapse and remission of proteinuria.

Methods

The examination was performed on 23 children and adolescents diagnosed with INS. Reference group consisted of 22 participants. The study was carried out twice: in the relapse of INS (A) and in remission of proteinuria during glucocorticoid treatment (B).

Results

OxLDL was higher in INS patients, in both examinations when compared with reference participants. hs-CRP showed no differences between nephrotic and healthy children. We found higher concentration of oxLDL in children, who where frequent relapsers. Cholesterol, triglycerides/high density lipoprotein cholesterol and platelets were higher in INS patients (both A and B) in comparison with healthy children.

Conclusions

We observed presence of pro-atherogenic lipid profile in INS. Elevation of oxLDL may reflect increased oxidative stress and higher risk of atherosclerosis in INS, therefore it seems to be relevant to find patients of risk of atherosclerosis to consider lipid lowering treatment with antioxidants.
Literature
1.
go back to reference Pavlova EL, Lilova M, Savov M (2005) Oxidative stress in children with kidney disease. Pediatr Nephrol 20:1599–1604CrossRefPubMed Pavlova EL, Lilova M, Savov M (2005) Oxidative stress in children with kidney disease. Pediatr Nephrol 20:1599–1604CrossRefPubMed
2.
go back to reference Mishra OP, Pooniya V, Ali Z et al (2008) Antioxidant status of children with acute renal failure. Pediatr Nephrol 23:2047–2051CrossRefPubMed Mishra OP, Pooniya V, Ali Z et al (2008) Antioxidant status of children with acute renal failure. Pediatr Nephrol 23:2047–2051CrossRefPubMed
3.
go back to reference Nakhjavani M, Esteghamati A, Asgarani F et al (2009) Association of oxidized low-density lipoprotein and transforming growth factor-beta in type 2 diabetic patients: a cross-sectional study. Transl Res 153:86–90CrossRefPubMed Nakhjavani M, Esteghamati A, Asgarani F et al (2009) Association of oxidized low-density lipoprotein and transforming growth factor-beta in type 2 diabetic patients: a cross-sectional study. Transl Res 153:86–90CrossRefPubMed
4.
go back to reference Nakakura H, Ashida A, Hirano K et al (2004) Oxidative stress in a rat model of nephrosis can be quantified by electron spin resonance. Pediatr Nephrol 19:266–270CrossRefPubMed Nakakura H, Ashida A, Hirano K et al (2004) Oxidative stress in a rat model of nephrosis can be quantified by electron spin resonance. Pediatr Nephrol 19:266–270CrossRefPubMed
5.
go back to reference El-Melegy NT, Mohamed NA, Sayed MM (2008) Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome. Pediatr Res 63:404–409CrossRefPubMed El-Melegy NT, Mohamed NA, Sayed MM (2008) Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome. Pediatr Res 63:404–409CrossRefPubMed
6.
go back to reference Fydryk J, Jacobson E, Kurzawska O et al (1998) Antioxidant status of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 12:751–754CrossRefPubMed Fydryk J, Jacobson E, Kurzawska O et al (1998) Antioxidant status of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 12:751–754CrossRefPubMed
7.
go back to reference Kamireddy R, Kavuri S, Devi S et al (2002) Oxidative stress in pediatric nephrotic syndrome. Clin Chim Acta 325:147–150CrossRefPubMed Kamireddy R, Kavuri S, Devi S et al (2002) Oxidative stress in pediatric nephrotic syndrome. Clin Chim Acta 325:147–150CrossRefPubMed
8.
go back to reference Ece A, Atamer Y, Gurkan F et al (2005) Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 20:1279–1284CrossRefPubMed Ece A, Atamer Y, Gurkan F et al (2005) Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 20:1279–1284CrossRefPubMed
9.
10.
go back to reference Mathew JL, Kabi BC, Rath B (2002) Anti-oxidant vitamins and steroid responsive nephrotic syndrome in Indian children. J Paediatr Child Health 38:450–457CrossRefPubMed Mathew JL, Kabi BC, Rath B (2002) Anti-oxidant vitamins and steroid responsive nephrotic syndrome in Indian children. J Paediatr Child Health 38:450–457CrossRefPubMed
11.
go back to reference Ece A, Atamer Y, Gurkan F et al (2004) Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephritic syndrome. Nephrology 9:366–373CrossRefPubMed Ece A, Atamer Y, Gurkan F et al (2004) Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephritic syndrome. Nephrology 9:366–373CrossRefPubMed
12.
go back to reference Holvoet P, Lee DH, Steffes M et al (2008) Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 299:2287–2293PubMedCentralCrossRefPubMed Holvoet P, Lee DH, Steffes M et al (2008) Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 299:2287–2293PubMedCentralCrossRefPubMed
13.
go back to reference Ishigaki Y, Oka Y, Katagiri H (2009) Circulating oxidized LDL: a biomarker and a pathogenic factor. Curr Opin Lipidol 20:363–369CrossRefPubMed Ishigaki Y, Oka Y, Katagiri H (2009) Circulating oxidized LDL: a biomarker and a pathogenic factor. Curr Opin Lipidol 20:363–369CrossRefPubMed
14.
go back to reference Zhang YC, Wei JJ, Wang F et al (2012) Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome. Cell Biochem Biophys 62:365–372CrossRefPubMed Zhang YC, Wei JJ, Wang F et al (2012) Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome. Cell Biochem Biophys 62:365–372CrossRefPubMed
16.
go back to reference Clark AG, Barratt TM (1999) Steroid-responsive nephritic syndrome. In: Barratt TM, Avner ED, Harmon WE (eds) Pediatric nephrology, 4th edn. Lippincott Williams & Wilkins, Baltimore, pp 731–747 Clark AG, Barratt TM (1999) Steroid-responsive nephritic syndrome. In: Barratt TM, Avner ED, Harmon WE (eds) Pediatric nephrology, 4th edn. Lippincott Williams & Wilkins, Baltimore, pp 731–747
17.
go back to reference Imakita M, Yutani C, Strong JP et al (2001) Second nation-wide study of atherosclerosis in infants, children and young adults in Japan. Atherosclerosis 155:487–497CrossRefPubMed Imakita M, Yutani C, Strong JP et al (2001) Second nation-wide study of atherosclerosis in infants, children and young adults in Japan. Atherosclerosis 155:487–497CrossRefPubMed
18.
go back to reference Marcovina SM, Albers JJ, Dati F et al (1991) International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. Clin Chem 37:1676–1682PubMed Marcovina SM, Albers JJ, Dati F et al (1991) International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. Clin Chem 37:1676–1682PubMed
19.
go back to reference Baer AN, Wortmann RL (2007) Myotoxicity associated with lipid-lowering drugs. Curr Opin Rheumatol 9:67–73 Baer AN, Wortmann RL (2007) Myotoxicity associated with lipid-lowering drugs. Curr Opin Rheumatol 9:67–73
20.
go back to reference Wang SJ, Tsau YK, Lu FL et al (2000) Hypovolemia and hypovolemic shock in children with nephrotic syndrome. Acta Paediatr Taiwan 41:179–183PubMed Wang SJ, Tsau YK, Lu FL et al (2000) Hypovolemia and hypovolemic shock in children with nephrotic syndrome. Acta Paediatr Taiwan 41:179–183PubMed
21.
go back to reference Savin VJ (1993) Mechanisms of proteinuria in noninflammatory glomerular diseases. Am J Kidney Dis 21:347–362CrossRefPubMed Savin VJ (1993) Mechanisms of proteinuria in noninflammatory glomerular diseases. Am J Kidney Dis 21:347–362CrossRefPubMed
22.
go back to reference Magil AB, Frohlich JJ, Innis SM et al (1993) Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. Kidney Int 43:1243–1250CrossRefPubMed Magil AB, Frohlich JJ, Innis SM et al (1993) Oxidized low-density lipoprotein in experimental focal glomerulosclerosis. Kidney Int 43:1243–1250CrossRefPubMed
23.
go back to reference Trachtman H, Gauthier B, Frank R et al (1996) Increased urinary nitrite excretion in children with minimal change nephrotic syndrome. J Pediatr 128:173–176CrossRefPubMed Trachtman H, Gauthier B, Frank R et al (1996) Increased urinary nitrite excretion in children with minimal change nephrotic syndrome. J Pediatr 128:173–176CrossRefPubMed
24.
go back to reference Rose RC, Bode AM (1993) Biology of free radical scavengers: an evaluation of ascorbate. FASEB J 7:1135–1142PubMed Rose RC, Bode AM (1993) Biology of free radical scavengers: an evaluation of ascorbate. FASEB J 7:1135–1142PubMed
25.
go back to reference Satoh K (1978) Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 90:37–43CrossRefPubMed Satoh K (1978) Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 90:37–43CrossRefPubMed
26.
go back to reference Lechner BL, Bockenhauer D, Iragorri S et al (2004) The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr Nephrol 19:744–748CrossRefPubMed Lechner BL, Bockenhauer D, Iragorri S et al (2004) The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr Nephrol 19:744–748CrossRefPubMed
27.
go back to reference Orzechowski A, Ostaszewski P, Wilczak J et al (2002) Rats with a glucocorticoid-induced catabolic state show symptoms of oxidative stress and spleen atrophy: the effects of age and recovery. J Vet Med A Physiol Pathol Clin Med 49:256–263CrossRefPubMed Orzechowski A, Ostaszewski P, Wilczak J et al (2002) Rats with a glucocorticoid-induced catabolic state show symptoms of oxidative stress and spleen atrophy: the effects of age and recovery. J Vet Med A Physiol Pathol Clin Med 49:256–263CrossRefPubMed
28.
go back to reference Kawamura T, Yoshioka T, Bills T et al (1991) Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries. Kidney Int 40:291–301CrossRefPubMed Kawamura T, Yoshioka T, Bills T et al (1991) Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries. Kidney Int 40:291–301CrossRefPubMed
30.
go back to reference De Beer FC, Soutar AK, Baltz ML et al (1982) Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med 156:230–242CrossRefPubMed De Beer FC, Soutar AK, Baltz ML et al (1982) Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med 156:230–242CrossRefPubMed
31.
go back to reference Da Luz PL, Favarato D, Faria-Neto JR Jr et al (2008) High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics 63:427–432PubMedCentralCrossRefPubMed Da Luz PL, Favarato D, Faria-Neto JR Jr et al (2008) High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics 63:427–432PubMedCentralCrossRefPubMed
Metadata
Title
Are oxidized low-density lipoprotein and C-reactive protein markers of atherosclerosis in nephrotic children?
Authors
A. Rybi-Szumińska
A. Wasilewska
J. Michaluk-Skutnik
B. Osipiuk-Remża
R. Fiłonowicz
M. Zając
Publication date
01-12-2015
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2015
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-014-1170-8

Other articles of this Issue 4/2015

Irish Journal of Medical Science (1971 -) 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine